Rani Therapeutics Holdings Inc (RANI) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Rani Therapeutics Holdings Inc   (NASDAQ: RANI)

Rani Therapeutics Holdings Inc Profitability Comparisons

Select each Category to receive further Information




RANI Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q3 MRQ) 0 % 66.11 % 55.66 % 38 %
Gross Margin (Q3 TTM) 0 % 67.89 % 55.54 % 37.65 %
Gross Profit Margin 5 Yr. Avg. - 66.08 % 54.71 % 32.75 %
EBITDA Margin (Q3 MRQ) 0 % 28.19 % 25.08 % 26.28 %
EBITDA Margin (Q3 TTM) 0.97 % 29.21 % 23.62 % 20.75 %
EBITDA Margin 5 Yr. Avg. - 40.53 % 30.23 % 22.74 %
Operating Margin (Q3 MRQ) -540.3 % 19.7 % 18.42 % 16.63 %
Operating Margin (Q3 TTM) -530.45 % 18.92 % 16.41 % 15.69 %
Operating Margin 5 Yr. Avg. - 15.26 % 14.36 % 15.96 %
Pre-Tax Profit Margin (Q3 MRQ) 0 % 17.45 % 14.44 % 13.79 %
Pre-Tax Profit Margin (Q3 TTM) 0 % 16.84 % 12.5 % 12.56 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.62 % 10.83 % 11.56 %
Net Margin (Q3 MRQ) -452.78 % 13.22 % 10.81 % 10.54 %
Net Margin (Q3 TTM) -504.85 % 15.07 % 10.57 % 10.17 %
Net Margin 5 Yr. Avg. - 7.44 % 6.8 % 9.04 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) -465.38 % 4.45 % 2.89 % -0.07 %
Free Cash Flow Margin (Q3 TTM) -352.45 % 16.63 % 13.53 % 8.82 %
Free Cash Flow Margin 5 Yr. Avg. - 23.43 % 17.59 % 16.03 %
Net Cash Flow Margin (Q3 MRQ) 0 % 3.52 % -1.18 % -1.72 %
Net Cash Flow Margin (Q3 TTM) 0 % 3.55 % 1.5 % 0.91 %
Net Cash Flow Margin 5 Yr. Avg. - 5.43 % 4.29 % 11.75 %
Effective Tax Rate (Q3 MRQ) - 24.11 % 24.32 % 21.95 %
Effective Tax Rate (Q3 TTM)